Australian Pesticides / Veterinary Medicines Authority BIP Biological Imports Program / APVMA / Russell / Veterinary Medicines Authority / Zoetis Australia Research & Manufacturing Pty Ltd / Food Standards Australia New Zealand / /
Country
Australia / United Kingdom / /
Event
FDA Phase / Product Issues / /
IndustryTerm
gene technology / microbial derived products / biological products / licence applications / Gene technology legislation / nucleotide search bp / chemical products / personal protective equipment / chemical agents / /
US Department of Agriculture / Department of Agriculture / Therapeutic Goods Administration / Australian Government / office of the Gene Technology Regulator / Australian Pesticide and Veterinary Medicines Authority / European Union / Regulator Gene Technology Regulator USA United States of America USDA US Department / Gene Technology Technical Advisory Committee / Asia-Pacific Economic Cooperation / office of the Gene Technology Regulator RARMP Risk Assessment / /
Position
Minister for the Environment / veterinarian / General / /
Product
sterile water / residual vaccine / E. coli chicken vaccine / biosynthesis / /
Risk Assessment and Risk Management Plan for DIR 125 Commercial release of genetically modified vaccine to protect chickens against pathogenic Escherichia coli Applicant: Zoetis Australia Research & Manufacturing Pty Ltd